UNIVERSITY OF MASSACHUSETTS AMHERST
The role of extracellular matrix quality in the prediction of metastasis-induced skeletal fragility and response to immunotherapy
The role of extracellular matrix quality in the prediction of metastasis-induced skeletal fragility and response to immunotherapy is a funding opportunity from UNIVERSITY OF MASSACHUSETTS AMHERST, up to 392617, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Metastatic bone disease (MBD) is a frequent and fatal complication in patients with advanced solid malignancies. Immune checkpoint inhibitors (ICIs) such as programmed cell death protein-1 (PD-1) have revolutionized cancer therapy over the past decade; however, the positive impact of ICIs in MBD is attenuated due to…